ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2

ISSN 印刷: 0893-9675
ISSN オンライン: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.v7.i3-4.40
pages 205-226

The Role of Metalloproteinases and Their Inhibitors in Hematological Disorders

Liliana Guedez
Laboratory of Pathology, National Cancer Institute, National Institutes of Health
Megan S. Lim
Laboratory of Pathology, National Cancer Institute, National Institutes of Health
William G. Stetler-Stevenson
Laboratory of Pathology, National Cancer Institute, National Institutes of Health

要約

The balance between the activities of matrix metalloproteinases (MMPs) and the tissue inhibitors of metalloproteinases (TIMPs) is an important control point during the turnover of the extracellular matrix. Previous studies have demonstrated that an uncontrolled rate of production of these proteins leads to various pathological conditions. Overexpression of MMPs by malignant cells can increase the invasive behavior of solid tumors and their metastatic potential. In an increasing number of reports, it has become evident that expression of MMPs and TIMPs is not restricted to solid tumors. Normal and malignant hematological cells also express these proteins and play a pivotal role in the hematological-cell physiology. In addition to modifying the extracellular matrix, MMPs and TIMPs exert other functions in hematological cells, including growth-factor activity, removal of cell-surface receptors, and autoimmunity. The goal of this review is to gather recent studies concerning the properties of MMPs and TIMPs in hematological cells, their regulation of gene expression, their cellular distribution, and their potential role in the pathogenesis of hematological disorders such as inflammation and neoplasia.


Articles with similar content:

Inducible Nitric Oxide Synthase/ Cyclooxygenase-2 Pathway Interaction: A Good Molecular Target for Cancer Treatment
Forum on Immunopathological Diseases and Therapeutics, Vol.1, 2010, issue 3
Emanuela Masini, Fabio Cianchi
Modulation of Tumor–Stromal Cell Interactions: A New Anti-Tumor Strategy Targeting the Tumor Microenvironment
Forum on Immunopathological Diseases and Therapeutics, Vol.4, 2013, issue 1
Manabu Kawada, Shuichi Sakamoto, Akio Nomoto
New Roles for Matrix Metalloproteinases in Metastasis
Critical Reviews™ in Immunology, Vol.25, 2005, issue 6
Melanie Demers, Yves St-Pierre, Julie Couillard, Simon Belanger
Therapeutic Intervention with Breast Cancer Metastasis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.12, 2002, issue 2
Dina Chelouche Lev, Janet E. Price
Endothelial Cells as Key Determinants of the Tumor Microenvironment: Interaction with Tumor Cells, Extracellular Matrix and Immune Killer Cells
Critical Reviews™ in Immunology, Vol.30, 2010, issue 6
Muhammad Zaeem Noman, Salem Chouaib, Claudine Kieda, Fathia Mami-Chouaib, Houssem Benlalam, Curzio Ruegg